Frequency of Pulmonary Arterial Hypertension among patients of liver cirrhosis presenting with Acute Respiratory Failure
نویسندگان
چکیده
Background: liver cirrhosis with respiratory failure is frequent cause of admission in critical care unit. Sometime no etiological factor other than hepatopulmonary syndrome is labelled. Does pulmonary arterial hypertension matters in hepatopulmonary syndrome? Aim: To assess the frequency of pulmonary hypertension among liver cirrhosis patients presenting with respiratory failure at Critical care unit Ittefaq Hospital Model Town Lahore Pakistan. Methods: Doppler echocardiography was performed for assessments of pulmonaryarterial systolic pressure (PASP) on 80 consecutive patients who were known case of liver cirrhosis (48) men and 32 women) aged > 20 years, admitted to critical care unit at Ittefaq Hospital Model Town Lahore with respiratory failure. Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity (TRJV) of at least 2.5 m per second which can be estimate pulmonary artery systolic pressure (PASP) equal or more than 25mmHg on transthoracic echocardiograpgy Results: Doppler-defined pulmonary arterial hypertension was diagnosed in 8.75% among 80 patients included in study using a cutoff of PASP ≥25 mmHg. Conclusion: The prevalence of PAH among adults liver cirrhotic patient is higher than that reported from the developed countries. Further assessment using invasive techniques is required coupled with analytical study design to predict the factors that favor the development of PAH among liver cirrhotic patients is required. Early detection of hepatopulmonary HPT may help in management plan in the form of liver transplant.
منابع مشابه
Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders.
End-stage liver disease and its complications are a leading cause of death among adults in the United States, and thousands of patients await liver transplantation. The liver plays a central role in health and homeostasis and thus the diseased liver leads to many deleterious effects on multiple organ systems, including the pulmonary system. We review the general effects of cirrhosis on the resp...
متن کاملEarly Effectiveness of Noninvasive Positive Pressure Ventilation on Right Ventricular Function in Chronic Obstructive Pulmonary Disease Subjects with Acute Hypercapnic Respiratory Failure
Introduction: Noninvasive positive pressure ventilation (NIPPV) has become an integral tool in the management of acute hypercapnic respiratory failure (AHRF) in chronic obstructive pulmonary disease (COPD). This study was performed to evaluate the early effects of NIPPV on pulmonary artery pressure (PAP), serum N-terminal pro BNP (NT-proBNP), and ventilatory parameters in the COPD patients with...
متن کاملPulmonary histopathological alterations in patients with acute respiratory failure: an autopsy study* Alterações histopatológicas pulmonares em pacientes com insuficiência respiratória aguda: um estudo em autópsias
Objective: To present the pulmonary histopathological alterations found in the autopsies of patients with acute respiratory failure (ARF) and determine whether underlying diseases and certain associated risk factors increase the incidence of these histopathological patterns. Methods: Final autopsy reports were reviewed, and 3030 autopsies of patients > 1 year of age with an underlying disease a...
متن کاملUnusual presentation for a patent ductus arteriosus.
A 63-yr-old black female, with a 1-yr history of hepatitis C and ascites was referred to an expert centre with suspicion of portopulmonary hypertension (PPHTN). Her poor condition made a rapid diagnosis imperative and precluded a normal diagnostic work-up. Echocardiography confirmed severe pulmonary hypertension (PH). A hepatic scintigraphy and an abdominal echo-Doppler study excluded liver cir...
متن کاملDyspnoea: a prognostic marker for idiopathic pulmonary fibrosis.
REFERENCES 1 Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219–1263. 2 Barst RJ, Rich S, Widlitz A, et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest 2002; 121: 1860–1868. 3 Hoeper MM, Olsson KM, Schneid...
متن کامل